Leucovorin and Autism: What We Know (and Don’t)

You may have noticed a lot of buzz lately about leucovorin, a prescription supplement being talked about as a way to help autistic kids communicate more, feel less irritable, and engage socially. As someone who’s spent years working closely with autistic children and families, my first instinct was curiosity mixed with caution. 

On the one hand, any approach that could ease everyday challenges is worth understanding. On the other hand, autism is complex, and the research behind new treatments can be surprising, and sometimes underwhelming. So before we get swept up in the hype, let’s take a closer look at what leucovorin actually is, what we know about it, and what we don’t.

What is Leucovorin?

Leucovorin is a form of folate, sometimes called folinic acid. In some rare cases, people have trouble getting folate from their blood into their brain. This is called Cerebral Folate Deficiency (CFD). It can happen for several reasons: genetic mutations affecting folate metabolism, or antibodies that block folate receptors in the brain. When this happens, folate supplements that require metabolism (like standard folic acid) may not be enough. Leucovorin, however, can cross the blood-brain barrier more easily and help restore folate in the central nervous system. In CFD, symptoms can include motor challenges, seizures, irritability, developmental regression, and sometimes features seen in autistic children, like language differences and sensory sensitivities.

What Does the Research Say About Leucovorin & Autism?

Here’s where things get tricky. Some small studies suggest leucovorin may help some autistic children, particularly those with a folate metabolism issue:

  • Some studies report improvements in expressive language, communication, daily living skills, attention, and social reciprocity.

  • Some reductions have been reported in irritability, repetitive behaviours, and aggression.

There have been limited clinical trials (~ 8 at the time of writing)

  • Some studies showed that children improved just as much without leucovorin

  • Some studies did not include a placebo group, making comparisons difficult 

  • Only around 250 children have ever received leucovorin in clinical trials 

So while leucovorin might help a small subset of autistic children who also have folate deficiencies, the data is extremely limited. Autism is complex, and a folate deficiency is not the cause of autism in most cases (some research suggests that ~ 38% of autistic individuals may also have a folate deficiency). 

Why the Buzz?

Leucovorin recently received attention when public figures and social media framed it as a “new therapy for autism.” This is problematic for a few reasons:

  1. Deficit-focused narratives: Some coverage frames autism as a problem to “fix,” ignoring autistic voices who ask for support, not cures.

  2. Limited research: FDA approval skipped the usual slow, rigorous process, so we don’t have robust, long-term evidence.

  3. Hype vs reality: Small numbers and mixed results are being presented as a breakthrough, which can give families false hope.

At the same time, we cannot ignore the real struggles of families of autistic kids with high support needs. Caring for a child in a world not built for them is challenging, and it’s natural to look for options. But it’s important to separate hope from hype.

Bottom Line

  • Leucovorin may help some children with autism who have a folate metabolism issue, but it is not a universal solution.

  • We do not yet know who it will help, at what dosage, or what the long-term effects are.

  • Avoid “cure” rhetoric. Autism is not a disease to be cured, but communication and quality of life can always be supported.

  • Families should always talk with their doctor before starting any pharmaceutical treatment. 

In short: we’re watching the research closely, but for now, leucovorin is an experimental option, not a miracle.

Supporting autistic children’s strengths and providing practical, everyday help remains the most reliable path forward.

Sources:

Batebi, N., Moghaddam, H. S., Hasanzadeh, A., Fakour, Y., Mohammadi, M. R. & Akhondzadeh, S. (2020). Folinic acid as adjunctive therapy in treatment of inappropriate speech in children with autism: A double-blind and placebo-controlled randomized trial. Child Psychiatry & Human Development. https://doi.org/10.1007/s10578-020-01072-8

 

Bent, S., Chen, Y., McDonald, M. G., Widjaja, F., Wahlberg, J. & Hendren, R. L. (2020). An examination of changes in urinary metabolites and behaviors with the use of leucovorin calcium in children with autism spectrum disorder (ASD). Advances in Neurodevelopmental Disorders. https://doi.org/10.1007/s41252-020-00157-8

 

Frye, R. E., Lane, A., Worner, A., Werner, B. A., McCarty, P. J., Scheck, A. C., Collins, H. L., Adelman, S. J., Quadros, E. V. & Rossignol, D. A. (2022). The soluble folate receptor in autism spectrum disorder: Relation to autism severity and leucovorin treatment. Journal of Personalized Medicine. https://doi.org/10.3390/jpm12122033

 

Frye, R. E., Slattery, J., Delhey, L., Furgerson, B., Strickland, T., Tippett, M., Sailey, A., Wynne, R., Rose, S., Melnyk, S., Jill James, S., Sequeira, J. M. & Quadros, E. V. (2016). Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial. Molecular Psychiatry. https://doi.org/10.1038/mp.2016.16

 

Panda, P. K., Sharawat, I. K., Saha, S., Gupta, D., Palayullakandi, A. & Meena, K. (2024). Efficacy of oral folinic acid supplementation in children with autism spectrum disorder: a randomized double-blind, placebo-controlled trial. European Journal of Pediatrics. https://doi.org/10.1007/s00431-024-05762-6

 

Renard, E., Leheup, B., Guéant-Rodriguez, R., Oussalah, A., Quadros, E. V. & Guéant, J. (2020). Folinic acid improves the score of Autism in the EFFET placebo-controlled randomized trial. Biochimie. https://doi.org/10.1016/j.biochi.2020.04.019

 

Rossignol, D. A. & Frye, R. E. (2021). Cerebral Folate Deficiency, Folate Receptor Alpha Autoantibodies and Leucovorin (Folinic Acid) Treatment in Autism Spectrum Disorders: A Systematic Review and Meta-Analysis. Journal of Personalized Medicine. https://doi.org/10.3390/jpm11111141

Wong, C. M., Tan, C. S., Koh, H. C., Gan, X., Hie, S. L., Saffari, S. E., Yeo, J. G. & Lam, J. C. M. (2024). Folinic acid as a treatment for autism in children: A within‐subjects open‐label study on safety and efficacy. International Journal of Developmental Neuroscience. https://doi.org/10.1002/jdn.10402

Next
Next

Bringing It All Together: How Elemenoe Supports Families Through Collaborative Autism Therapy